Matrix Metalloproteinases Expression Is Associated with SARS-CoV-2-Induced Lung Pathology and Extracellular-Matrix Remodeling in K18-hACE2 Mice.
Hila GutmanMoshe AftalionSharon MelamedBoaz PolitiReinat NevoSapir Havusha-LauferHagit AchdoutDavid GurTomer IsraelyShlomit DachirEmanuelle MamroudIrit SagiYaron VagimaPublished in: Viruses (2022)
The COVID-19 pandemic caused by the SARS-CoV-2 infection induced lung inflammation characterized by cytokine storm and fulminant immune response of both resident and migrated immune cells, accelerating alveolar damage. In this work we identified members of the matrix metalloprotease (MMPs) family associated with lung extra-cellular matrix (ECM) destruction using K18-hACE2-transgenic mice (K18-hACE2) infected intranasally with SARS-CoV-2. Five days post infection, the lungs exhibited overall alveolar damage of epithelial cells and massive leukocytes infiltration. A substantial pulmonary increase in MMP8, MMP9, and MMP14 in the lungs post SARS-CoV-2 infection was associated with degradation of ECM components including collagen, laminin, and proteoglycans. The process of tissue damage and ECM degradation during SARS-CoV-2 lung infection is suggested to be associated with activity of members of the MMPs family, which in turn may be used as a therapeutic intervention.
Keyphrases
- sars cov
- extracellular matrix
- respiratory syndrome coronavirus
- oxidative stress
- immune response
- diabetic rats
- high glucose
- randomized controlled trial
- cell migration
- pulmonary hypertension
- type diabetes
- poor prognosis
- patient safety
- metabolic syndrome
- quality improvement
- binding protein
- skeletal muscle
- wound healing
- insulin resistance